Log in to search using one of your social media accounts:

 

Most Popular NEJM Group Feature This Week: Aspirin in Heart Failure (FREE)
By the Editors Here's the most clicked-on item we … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 16, 2017 Category: Primary Care Source Type: news

Bayer receives positive CHMP opinion for rivaroxaban 10 mg once daily for the extended prevention of venous thromboembolism (for specialized target groups only)
Rivaroxaban 10 mg once daily significantly reduces the risk of recurrent venous thromboembolism compared with aspirin 100 mg once daily after at least six months of standard anticoagulation therapy / Positive CHMP Opinion is based on data from the Phase III EINSTEIN CHOICE study / Final European Commission decision expected by November 2017 (Source: Bayer Company News)
Source: Bayer Company News - September 15, 2017 Category: Pharmaceuticals Source Type: news

Type 2 diabetics should take aspirin twice a day
Researchers from Aarhus University Hospital in Denmark found that when aspirin is taken the recommended once a day, patients suffer an increased risk of blood clotting between doses. (Source: the Mail online | Health)
Source: the Mail online | Health - September 13, 2017 Category: Consumer Health News Source Type: news

Small study backs aspirin twice a day for type 2 diabetics
Taking aspirin twice a day rather than just once may increase the chances of staving off cardiovascular disease in people with type 2 diabetes, suggests a new small-scale study. (Source: Nursing Times)
Source: Nursing Times - September 13, 2017 Category: Nursing Source Type: news

Type 2 diabetes - patients could take THIS medicine to protect against heart attack
TYPE 2 diabetes can increase the risk of heart attack and stroke - but experts believe taking aspirin could protect patients. (Source: Daily Express - Health)
Source: Daily Express - Health - September 12, 2017 Category: Consumer Health News Source Type: news

Diabetes news: Taking aspirin TWICE a day could help protect Type 2 sufferers
TAKING aspirin twice a day - rather than the currently recommended once daily - could help protect people with type 2 diabetes from suffering a heart attack or stroke, according to new research. (Source: Daily Express - Health)
Source: Daily Express - Health - September 12, 2017 Category: Consumer Health News Source Type: news

Do You Listen to Heart Sounds? This May be Another Reason Why You Should.
I’m not sure about you, but when I went to school to become a paramedic (and a nurse for that matter), one thing I never really understood was heart sounds, or heart tones, depending on who taught you. My attempt at learning resorted to scouring textbooks, journals, online editorials, watching clips on YouTube and listening… lots of listening to sound bites from CDs. You know the ones, they come free when you buy a new stethoscope. Instead of turning to digital media, I should’ve been listening to the hearts of my patients. Hindsight is 20/20, especially in this case. All my self-guided education yielded...
Source: JEMS Patient Care - September 12, 2017 Category: Emergency Medicine Authors: Bruce Hoffman, MSN,BSN-RN, NR-P, CFRN Tags: Patient Care Cardiac & Resuscitation Source Type: news

Kawasaki Disease: High- or Low-Dose Aspirin? Kawasaki Disease: High- or Low-Dose Aspirin?
Which approach is best in preventing coronary artery abnormalities in children with Kawasaki disease?Medscape Pediatrics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2017 Category: Consumer Health News Tags: Pediatrics Viewpoint Source Type: news

Here ’s Why Most Americans Prefer to Treat Pain Without Drugs
In the midst of an opioid addiction epidemic, a new survey of Americans has found that most prefer to try a non-drug approach to treating their pain over taking medications prescribed by their doctor. The new report, part of the Gallup-Palmer College of Chiropractic Annual Study of Americans, surveyed about 6,300 adults. Nearly two thirds said that they had neck or back pain so great they sought a health care provider for relief, and 54% said they had neck or back pain for at least five years. Yet 78% said they preferred to try other ways to address their physical pain before taking drugs. Still, many Americans said they ...
Source: TIME.com: Top Science and Health Stories - September 12, 2017 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Addiction Back Pain back pain relief chronic pain Gallup Heroin how to treat back pain how to treat pain natural pain relief Opioid opioids pain killers prescription pain killers Source Type: news

Your NEJM Group Today: Severe Asthma Review / Aspirin in Heart Failure / Missouri IM Opportunities (FREE)
By the Editors Here is what we selected for you from NEJM Group:NEJM Clinical Practice Center: Review article: Adults with … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 11, 2017 Category: Primary Care Source Type: news

Aspirin 'can RE-GROW rotting teeth by being used to fill cavities'
DENTAL experts will today outline a revolutionary plan to “re-grow” rotten teeth by using aspirin to fill cavities. (Source: Daily Express - Health)
Source: Daily Express - Health - September 7, 2017 Category: Consumer Health News Source Type: news

Belfast scientists say aspirin could reverse tooth decay
Research finds aspirin stimulates the regeneration of damaged tooth structure. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 7, 2017 Category: Consumer Health News Source Type: news

Arthritis drug warning: Taking THIS common medication could lead to hearing loss
ARTHRITIS sufferers are often given an aspirin-like drug, diflunisal, to reduce inflammation. But researchers have discovered it may cause hearing loss. (Source: Daily Express - Health)
Source: Daily Express - Health - September 7, 2017 Category: Consumer Health News Source Type: news

Aspirin could REVERSE the effects of tooth decay
Aspirin helps form new dentine – the hard tooth structure damaged by decay – found a Queen's University Belfast study. The findings could result in a reduction in the need for fillings. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2017 Category: Consumer Health News Source Type: news

Bowel cancer: Taking THIS common drug could protect against disease - but there's a catch
BOWEL cancer is one of the most common types of cancer in the UK - but taking an aspirin every day can help stave off the disease. However, there is a catch. (Source: Daily Express - Health)
Source: Daily Express - Health - September 6, 2017 Category: Consumer Health News Source Type: news

COMPASS: Don't Pop the Champagne Yet COMPASS: Don't Pop the Champagne Yet
Dr John Mandrola is not convinced that the COMPASS trial findings warrant adding low-dose of rivaroxaban twice daily on top of aspirin to an already pill-burdened patient population.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 31, 2017 Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news

Xarelto, aspirin combo reduces risk of cardiovascular events in pivotal Ph3 trial
Johnson & Johnson (NYSE:JNJ) subsidiary Janssen touted data today from a pivotal Phase III trial showing that Xarelto plus aspirin reduced the risk of major cardiovascular events in patients with stable coronary and peripheral artery disease compared to aspirin alone. Treatment with Xarelto twice per day and aspirin once-daily cut the risk of major cardiovascular events by 24%, including a 42% reduction in strokes and a 22% reduction in cardiovascular death, the company reported. Get the full story at our sister site, Drug Delivery Business News. The post Xarelto, aspirin combo reduces risk of cardiovascular event...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Pharmaceuticals Wall Street Beat Bayer Janssen Pharmaceuticals johnsonandjohnson Source Type: news

News from the ESC Congress: Anti-Inflammatory Drug Cuts CV Events / Rivaroxaban+Aspirin / More... (FREE)
By the Editors NEJM Journal Watch is covering the European Society of Cardiology Congress in Barcelona this week. Here are highlights from some of the presented trials:CANTOS: Canakinumab, an anti-inflammatory drug that inhibits interleukin-1 beta, showed modest benefits in treating atherosclerotic disease, but there were … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 28, 2017 Category: Primary Care Source Type: news

COMPASS: Rivaroxaban Reduces CV and Limb Events in PAD COMPASS: Rivaroxaban Reduces CV and Limb Events in PAD
The combination of low-dose rivaroxaban plus aspirin has become the first drug regimen to show a clear-cut reduction in both cardiovascular and limb events, including amputations, in patients with peripheral arterial disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 27, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

ESC: NOAC Combo Tx Can Eliminate Need for Aspirin After PCI
(MedPage Today) -- Fewer bleeds and similar ischemic protection seen in RE-DUAL trial (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 27, 2017 Category: Cardiology Source Type: news

COMPASS: Rivaroxaban Success in Secondary CV Prevention COMPASS: Rivaroxaban Success in Secondary CV Prevention
The combination of a low dose of the factor Xa inhibitor rivaroxaban in combination with aspirin was associated with a reduction in ischemic events and mortality and a superior net clinical benefit, balancing the bleeding risk in patients with stable atherosclerotic disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 27, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Bayer ’s Xarelto® significantly lowered the combined risk of stroke, cardiovascular death and heart attack in patients with chronic coronary or peripheral artery disease by 24% (for specialized target groups only)
Importantly, rivaroxaban vascular dose, 2.5 mg twice daily, plus aspirin 100 mg once daily showed an unprecedented 42% relative risk reduction in stroke and 22% in cardiovascular death compared with aspirin 100 mg once daily alone / Bleeding rates were low, and while major bleeding was increased, notably there was no significant increase in intracranial or fatal bleeding / This combination regimen demonstrated a substantial improvement in net clinical benefit of 20% (Source: Bayer Company News)
Source: Bayer Company News - August 27, 2017 Category: Pharmaceuticals Source Type: news

ESC: Ultra-Low Dose NOAC Aids Outcomes in Stable CVD (CME/CE)
(MedPage Today) -- 2.5-mg rivaroxaban plus aspirin showed mortality trend, too (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 27, 2017 Category: Cardiology Source Type: news

Researchers find combination therapy works best for heart diseases
(McMaster University) A major international study has found that the combination of two drugs -- rivaroxaban and aspirin -- is superior to aspirin alone in preventing further heart complications in people with vascular disease.The study of 27,400 people with stable coronary or peripheral artery disease from 33 countries worldwide shows that the combination of 2.5 mg of rivaroxaban twice daily plus 100 mg of aspirin once daily was significantly better than only aspirin or only rivaroxaban in preventing heart attacks, strokes and death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2017 Category: International Medicine & Public Health Source Type: news

Extended treatment with Brilinta reduces risk of cardiovascular death by 29% in patients with history of heart attack
AstraZeneca today announced results from a new sub-analysis of data from the Phase III PEGASUS-TIMI 54 trial demonstrating a 29% risk reduction in CV death (p=0.0041) from treatment with Brilinta (ticagrelor) 60mg twice daily, versus placebo, in patients taking low-dose aspirin but still at high risk of an atherothrombotic event, a major cause of acute coronary syndrome and CV death. (Source: World Pharma News)
Source: World Pharma News - August 24, 2017 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 14, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Abbott’s new contact ablation catheter: Here’s what you need to know The new TactiCath contact ablation catheter unites EndoSense and St. Jude Medical technologies that Abbott acquired, marrying fiber optics, flexib...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Medtronic launches DAPT study for Resolute Onyx DES
Medtronic (NYSE:MDT) said today that it’s launching a study of dual anti-platelet therapy and its Resolute Onyx drug-eluting stent. The 2,000-patient study is designed to compare a one-month course of aspirin and an anti-coagulant in conjunction with the Resolute Onyx device or the BioFreedom DES made by Biosensors International (PINK:BSNRY). The Resolute Onyx stent is made from a single strand of cobalt alloy, formed into a sinusoidal wave with a radio-opaque core, Medtronic said. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic launches DAPT study for Resolute Onyx DES app...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Drug-Device Combinations Stents Medtronic Source Type: news

Soma Compound (Carisoprodol and Aspirin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 7, 2017 Category: Drugs & Pharmacology Source Type: news

Study: Aspirin Safe for HF Patients (CME/CE)
(MedPage Today) -- Post-hoc WARCEF trial analysis shows no significant risks vs warfarin (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 1, 2017 Category: Cardiology Source Type: news

New Research Supports Safety of Aspirin in Heart Failure
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 1, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Aspirin Safe for Heart Failure Patients, Study Finds
Title: Aspirin Safe for Heart Failure Patients, Study FindsCategory: Health NewsCreated: 7/31/2017 12:00:00 AMLast Editorial Review: 8/1/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - August 1, 2017 Category: Cardiology Source Type: news

Aspirin safe for heart failure patients, study finds
A new study found that those on daily aspirin were not at heightened risk of being hospitalized for, or dying from, heart failure. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 1, 2017 Category: Consumer Health News Source Type: news

Study: Aspirin Safe for Heart Failure Patients
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths (Source: WebMD Health)
Source: WebMD Health - July 31, 2017 Category: Consumer Health News Source Type: news

Aspirin Safe for Heart Failure Patients, Study Finds
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths Source: HealthDay Related MedlinePlus Pages: Blood Thinners, Heart Failure (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 31, 2017 Category: Consumer Health News Source Type: news

Aspirin Safe for Heart Failure Patients, Study Finds
MONDAY, July 31, 2017 -- Some research has raised concerns about the safety of aspirin for heart failure patients. But a new study appears to offer some reassurance. The study, of over 2,300 patients, found that those on daily aspirin were not at... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 31, 2017 Category: General Medicine Source Type: news

Patients With TIA or Stroke on Aspirin May Benefit From Another Antiplatelet Drug Patients With TIA or Stroke on Aspirin May Benefit From Another Antiplatelet Drug
Patients who have a transient ischemic attack (TIA) or stroke while they're on aspirin may have better vascular health and avoid future strokes if they add or switch to another antiplatelet agent within days, a new meta-analysis suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 25, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Questionable Value for Ticagrelor in Long-Term Use (CME/CE)
(MedPage Today) -- Each QALY costs nearly $100,000 more than aspirin (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 24, 2017 Category: American Health Source Type: news

Heparin, ASA Aids Live Birth With Antiphospholipid Antibody Heparin, ASA Aids Live Birth With Antiphospholipid Antibody
Unfractionated heparin added to aspirin is superior to aspirin alone in promoting live births among women with antiphospholipid syndrome and recurrent pregnancy loss, a meta-analysis shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 20, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Antiplatelet drugs are often inappropriately prescribed in older patients
(Wiley) A study has found that antiplatelet drugs, such as aspirin, are often inappropriately prescribed in acutely hospitalized older people. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 19, 2017 Category: International Medicine & Public Health Source Type: news

The Risk of Lower GI Bleeding in Low-dose Aspirin Users The Risk of Lower GI Bleeding in Low-dose Aspirin Users
How significant is the risk of lower gastrointestinal bleeding in low-dose aspirin users?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Heartburn drugs linked to premature death
Conclusion This larger set of observational data finds that PPI drugs are associated with an increase in the risk of early death compared with either H2 blockers or no acid suppression drugs. This was the case for participants both with and without gastrointestinal problems. It also appears as though the longer the PPIs drugs are taken, the greater the risk of death. Considering that these drugs are widely used in the UK, these findings may cause concern. But the research has a number of important limitations: The study was conducted in a population of mostly white, older US male veterans, which might limit the abi...
Source: NHS News Feed - July 4, 2017 Category: Consumer Health News Tags: Medication Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include a novel vaccine delivery method, aspirin and preeclampsia, air pollution and mortality in seniors, and exercise and dementia (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - July 1, 2017 Category: Psychiatry Source Type: news

5 Questions you can answer with NCBI Protein and Structure Databases
Protein sequences are the fundamental determinants of biological structure and function. Learn how to use the Protein and Structure Databases from NCBI to find information about the biological structure and function of proteins in this upcoming webinar! July 26, 1:00-2:00 PM ET Details and Registration In this webinar, you will learn about the Protein and Structure databases and how to use them to answer questions such as*: How can I find a RefSeq protein of interest? How can I find the NCBI Reference Genomic Sequence, transcript , and protein sequence for a given gene and organism? How do I retrieve all structures from a...
Source: NN/LM Middle Atlantic Region Blog - June 29, 2017 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Education Source Type: news

Pulmonary vein stenosis: A clinical trial in Jack ’s juice glass
At just 6 months old, Jack Marquis was suddenly given four weeks to live. After he was born with complex congenital heart defects, Jack’s doctors in California had performed two open-heart surgeries that they thought would save Jack’s life. But just when they thought he was out of the woods, Jack’s condition suddenly began to deteriorate rapidly. “On top of everything else, we learned he had a rare condition called pulmonary vein stenosis,” says Jack’s father, Andrew. Racing to treat pulmonary vein stenosis Pulmonary vein stenosis causes narrowing of the veins that carry oxygen-rich bloo...
Source: Thrive, Children's Hospital Boston - June 29, 2017 Category: Pediatrics Authors: Kat J. McAlpine Tags: Our Patients’ Stories Research and Innovation chemotherapy clinical trial Dana-Farber/Boston Children's Cancer and Blood Disorders Center Dr. Kathy Jenkins Dr. Mark Kieran Heart Center pulmonary vein stenosis Source Type: news

Low-Dose Aspirin Beginning Early in Pregnancy Helps Prevent Preterm Preeclampsia (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD Use of low-dose aspirin lowers the risk for preeclampsia among women determined to be at high risk during first-trimester screening, according to a study presented at a meeting of the … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 29, 2017 Category: Primary Care Source Type: news

Aspirin Cuts Preterm Preeclampsia in High-Risk Women Aspirin Cuts Preterm Preeclampsia in High-Risk Women
Low-dose aspirin reduced the incidence of preterm preeclampsia among pregnant women at high risk for the condition, a new study has found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Daily Aspirin Cuts Preterm Preeclampsia in High-Risk Women (CME/CE)
(MedPage Today) -- Preterm delivery risk significantly lower with aspirin versus placebo (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 28, 2017 Category: Cardiology Source Type: news

Aspirin a Day to Keep Pregnancy Problems Away?
Odds of preeclampsia dropped 62 percent for high-risk women who took a daily pill, study finds (Source: WebMD Health)
Source: WebMD Health - June 28, 2017 Category: Consumer Health News Source Type: news

When Can a Doctor Help Your Back Pain?
Treatment TermsBack pain TagsBack pain Sub-Title Answers to Common Back Pain Questions Overview More than eight in 10 people will experience back pain at some point in their lives. In most cases, the pain goes away over time. If your back pain is severe or does not improve, you may need medical care. Here are answers to some common questions about back pain and tips on when to seek help. Content Blocks Header Why Does My Back Hurt? ContentThere are various reasons why your back can hurt, including muscle pain, disc pain, joint pain, or nerve pain. In most cases, these are not harmful or dangerous. “There are...
Source: dukehealth.org: Duke Health News - June 28, 2017 Category: Consumer Health News Authors: mf205 at duke.edu Source Type: news

Can an Aspirin a Day Keep a Pregnancy Complication Away?
Odds of preeclampsia dropped 62 percent for high-risk women who took a daily pill, study finds Source: HealthDay Related MedlinePlus Pages: Blood Thinners, Health Problems in Pregnancy, High Blood Pressure in Pregnancy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 28, 2017 Category: Consumer Health News Source Type: news